Exploiting glycan topography for computational design of Env glycoprotein antigenicity
Name
journal.pcbi.1006093.pdf
Size
7.64 MB
Format
Adobe PDF
Checksum (MD5)
23e0af4a16985b86898144cde828c427
Author(s) • • • • • • • • •
Zhao, Peng
Draghi, Monia
Arevalo, Claudia
Karsten, Christina B.
Suscovich, Todd J.
Gunn, Bronwyn
Streeck, Hendrik
Brass, Abraham L.
Tiemeyer, Michael
Seaman, Michael
Date Issued
April 2018
Journal
PLOS Computational Biology
Publisher
Public Library of Science
Citation
Yu, Wen-Han, Peng Zhao, Monia Draghi, Claudia Arevalo, Christina B. Karsten, Todd J. Suscovich, Bronwyn Gunn, et al. “Exploiting Glycan Topography for Computational Design of Env Glycoprotein Antigenicity.” Edited by Greg Tucker-Kellogg. PLOS Computational Biology 14, 4 (April 2018): e1006093 © 2018 Public Library of Science (PLoS)
Version
Final published version
Abstract
Mounting evidence suggests that glycans, rather than merely serving as a “shield”, contribute critically to antigenicity of the HIV envelope (Env) glycoprotein, representing critical antigenic determinants for many broadly neutralizing antibodies (bNAbs). While many studies have focused on defining the role of individual glycans or groups of proximal glycans in bNAb binding, little is known about the effects of changes in the overall glycan landscape in modulating antibody access and Env antigenicity. Here we developed a systems glycobiology approach to reverse engineer the complexity of HIV glycan heterogeneity to guide antigenicity-based de novo glycoprotein design. bNAb binding was assessed against a panel of 94 recombinant gp120 monomers exhibiting defined glycan site occupancies. Using a Bayesian machine learning algorithm, bNAb-specific glycan footprints were identified and used to design antigens that selectively alter bNAb antigenicity as a proof-of concept. Our approach provides a new design strategy to predictively modulate antigenicity via the alteration of glycan topography, thereby focusing the humoral immune response on sites of viral vulnerability for HIV.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution 4.0 International License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1371/journal.pcbi.1006093